(Q40864279)

24 September 2017

1 reference

title

Meningococcal vaccines. Current status and future possibilities (English)

1 reference

24 September 2017

Peltola H

1

1 reference

24 September 2017

publication date

1 March 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

55

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

347-366

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855030-00003

24 September 2017

exact match

0 references

cites work

Meningococcal Disease: Still with Us

1 reference

12 December 2020

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

12 December 2020

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

12 December 2020

Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria

1 reference

12 December 2020

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

12 December 2020

Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland

1 reference

12 December 2020

Recent changes in meningococcal disease in Europe

1 reference

12 December 2020

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

12 December 2020

Control of meningococcal infection in the African meningitis belt by selective vaccination

1 reference

12 December 2020

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

12 December 2020

Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates

1 reference

12 December 2020

A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A

1 reference

12 December 2020

Serogroup B meningococcal disease--Oregon, 1994

1 reference

12 December 2020

Effectiveness of BC meningococcal vaccine in Brazil

1 reference

12 December 2020

Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization

1 reference

12 December 2020

Effect of group-A meningococcal vaccine in army recruits in Finland

1 reference

12 December 2020

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp

1 reference

12 December 2020

Vaccination campaign against meningococcal disease in army recruits in Italy

1 reference

12 December 2020

Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children

1 reference

12 December 2020

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

12 December 2020

Meningococcal disease: was Ottawa's mass-vaccination program necessary?

1 reference

12 December 2020

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

1 reference

12 December 2020

The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes

1 reference

12 December 2020

Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease.

1 reference

12 December 2020

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba

1 reference

12 December 2020

Outbreak of infection caused by Neisseria meningitidis group C type 2 in a nursery.

1 reference

12 December 2020

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination

1 reference

12 December 2020

Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide

1 reference

12 December 2020

Should college students be vaccinated against meningococcal disease? A cost-benefit analysis

1 reference

12 December 2020

Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide

1 reference

12 December 2020

Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide

1 reference

12 December 2020

Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: immunogenicity and safety

1 reference

12 December 2020

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

1 reference

12 December 2020

Serotherapy of cerebrospinal meningitis

1 reference

12 December 2020

Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand

1 reference

12 December 2020

Immunization during a cerebrospinal meningitis epidemic in the Mongolian People's Republic, 1974-75

1 reference

12 December 2020

Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988

1 reference

12 December 2020

Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100

1 reference

12 December 2020

An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations

1 reference

12 December 2020

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

12 December 2020

Meningococcal vaccine trial in Norway

1 reference

12 December 2020

Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.

1 reference

12 December 2020

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

12 December 2020

An outbreak of meningococcal disease in Ottawa-Carleton. December 1991-February 1992

1 reference

12 December 2020

Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.

1 reference

12 December 2020

Group C Neisseria meningitidis variant polysaccharide vaccines in children

1 reference

12 December 2020

Epidemic group A meningococcal disease in Haj pilgrims

1 reference

12 December 2020

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

1 reference

12 December 2020

Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide

1 reference

12 December 2020

Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria

1 reference

12 December 2020

Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults

1 reference

12 December 2020

Development of polysaccharide vaccines for the prevention of meningococcal diseases

1 reference

12 December 2020

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

12 December 2020

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

12 December 2020

Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992.

1 reference

12 December 2020

Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

1 reference

12 December 2020

Epidemiology and prevention of meningococcal disease

1 reference

12 December 2020

Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination

1 reference

12 December 2020

On the controversy about the efficacy of the antimeningococcal B vaccine: methodological pitfalls

1 reference

12 December 2020

Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.

1 reference

12 December 2020

Meningitis outbreaks and vaccination strategy

1 reference

12 December 2020

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

1 reference

12 December 2020

Early meningococcal disease: advising the public and the profession

1 reference

12 December 2020

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

1 reference

12 December 2020

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

12 December 2020

1 reference

12 December 2020

Prevention of secondary cases of meningococcal disease in household contacts by vaccination

1 reference

12 December 2020

Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination

1 reference

12 December 2020

Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design

1 reference

12 December 2020

Serogroup C meningococcal outbreaks in the United States. An emerging threat

1 reference

12 December 2020

School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis

1 reference

12 December 2020

Impairment of the immune response to vaccination after acute malaria

1 reference

12 December 2020

A controlled field trial of a serogroup A meningococcal polysaccharide vaccine

1 reference

12 December 2020

Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic

1 reference

12 December 2020

Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine

1 reference

12 December 2020

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

12 December 2020

Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein

1 reference

12 December 2020

Epidemic meningococcal disease in an elementary-school classroom

1 reference

12 December 2020

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

12 December 2020

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

1 reference

12 December 2020

The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.

1 reference

12 December 2020

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

12 December 2020

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

12 December 2020

Group A Meningococcal Polysaccharide Vaccine and Course of the Group A Meningococcal Epidemic in Finland

1 reference

12 December 2020

Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide

1 reference

12 December 2020

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

12 December 2020

Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70

1 reference

12 December 2020

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

12 December 2020

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

12 December 2020

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

12 December 2020

The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus

1 reference

12 December 2020

Control of epidemic group A meningococcal meningitis in Nepal

1 reference

12 December 2020

Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines

1 reference

12 December 2020

Vaccine against meningococcal group B disease

1 reference

12 December 2020

Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins

1 reference

12 December 2020

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

1 reference

12 December 2020

Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

1 reference

12 December 2020

Control of epidemic meningococcal meningitis by mass vaccination.

1 reference

12 December 2020

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

1 reference

12 December 2020

Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy

1 reference

12 December 2020

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

12 December 2020

Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy

1 reference

12 December 2020

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

12 December 2020

[Evaluation of the protection received by a BC antimeningococcal vaccine in the State of Santa Catarina, Brazil, 1990/92]

1 reference

12 December 2020

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

1 reference

12 December 2020

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

1 reference

12 December 2020

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

12 December 2020

Clinical and Serological Evaluation of a Meningococcal Polysaccharide Vaccine Groups A, C, and Y

1 reference

12 December 2020

PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS.

1 reference

12 December 2020

Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society

1 reference

12 December 2020

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.

1 reference

12 December 2020

Complement-Mediated Bactericidal Activity of Human Antibodies to Poly 2->8 N-Acetylneuraminic Acid, the Capsular Polysaccharide of Neisseria meningitidis Serogroup B

1 reference

12 December 2020

Meningococcal meningitis group A: a successful control of an outbreak by mass vaccination

1 reference

12 December 2020

Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.

1 reference

12 December 2020

CEREBROSPINAL MENINGITIS IN AFRICA

1 reference

12 December 2020

A somatic antigen vaccine for the prevention of meningococcal cerebrospinal meningitis

1 reference

12 December 2020

Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines

1 reference

12 December 2020

Prophylactic Vaccination in Epidemic Meningococcal Meningitis

1 reference

12 December 2020

Effectiveness of meningococcal vaccine in Brazil.

1 reference

12 December 2020

Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease

1 reference

12 December 2020

[The post-licensing efficacy of VA-MENGOC-BC in children under 6 in Holguín, Cuba. The first year of observation]

1 reference

12 December 2020

The risk of meningitis among classroom contacts during an epidemic of meningococcal disease

1 reference

12 December 2020

10.2165/00003495-199855030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1007069680

0 references

Fatcat ID

release_hiegbaxnirgvnkamvmrugjzcmq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hiegbaxnirgvnkamvmrugjzcmq

24 November 2022

mapped directly with Wikidata item

1 reference